Singapore markets close in 17 minutes

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
511.77-3.91 (-0.76%)
At close: 4:02PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
2,311,659
2,311,659
2,289,415
2,160,153
2,068,172
Cost of revenue
1,054,663
1,054,663
1,066,264
972,754
930,085
Gross profit
1,256,996
1,256,996
1,223,151
1,187,399
1,138,087
Operating expenses
Research development
202,710
202,710
199,196
250,301
205,864
Selling general and administrative
824,625
824,625
834,783
808,942
816,724
Total operating expenses
1,027,335
1,027,335
1,033,979
1,059,243
1,022,588
Operating income or loss
229,661
229,661
189,172
128,156
115,499
Interest expense
23,416
23,416
23,962
21,914
21,942
Total other income/expenses net
2,024,342
2,024,342
320,856
-27,534
-66,647
Income before tax
2,261,081
2,261,081
512,659
97,805
41,560
Income tax expense
502,406
502,406
147,045
-24,444
13,435
Income from continuing operations
1,758,675
1,758,675
365,614
122,249
28,125
Net income
1,758,675
1,758,675
365,614
122,249
28,125
Net income available to common shareholders
1,758,675
1,758,675
365,614
122,249
28,125
Basic EPS
-
58.93
12.10
3.87
0.96
Diluted EPS
-
58.27
11.94
3.82
0.95
Basic average shares
-
29,843
29,836
29,655
29,440
Diluted average shares
-
30,184
30,228
30,034
29,646
EBITDA
-
2,418,697
674,721
268,419
206,402